Bedtime nasal spray shows promise in alleviating sleep apnea severity and lowering blood pressure, offering hope to millions globally as per a study published in The Journal of Heart and ...
for neffy® (epinephrine nasal spray), for the treatment of Type I allergic reactions including anaphylaxis. The submission follows receipt of a Complete Response Letter (CRL) from the FDA in ...
A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: a randomized, blinded, trial. Am J Physiol Heart Circ Physiol . 2024;326(3):H715-H723. doi:10. ...
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer ... committee member for Milestone Pharmaceuticals, the maker of etripamil and ...
for neffy ® (epinephrine nasal spray), for the treatment of Type I allergic reactions including anaphylaxis. The submission follows receipt of a Complete Response Letter (CRL) from the FDA in ...
Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen ... profile for neffy (16:6 for adults and 17:5 for ...
for neffy® (epinephrine nasal spray), for the treatment of Type I allergic reactions including anaphylaxis. The submission follows receipt of a Complete Response Letter (CRL) from the FDA in ...
Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen ... profile for neffy (16:6 for adults and 17:5 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results